Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lei-Yun Wang
Clinical Efficacy and Safety of Afatinib in the Treatment of Non-Small-Cell Lung Cancer in Chinese Patients
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Afatinib Treatment in Advanced Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
Chinese Perspectives on Clinical Efficacy and Safety of Alectinib in Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Efficacy and Safety of Crizotinib Among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients
PLoS ONE
Multidisciplinary
Observational Study on the Efficacy and Safety of Erlotinib in Patients With Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer
Oncotarget
Oncology
Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Clinical Analysis of EGFR‐ Positive Non‐small Cell Lung Cancer Patients Treated With First‐line Afatinib: A Nagano Lung Cancer Research Group
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
OA10.04 Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results From SWOG S1403
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary